baber/WOPTO huggingface dataset:
Patent EP-4032116-A1 (EP)
Inventor: HIKMET RIFAT ATA MUSTAFA
IPC: H01L33/50
Filed: 2020-09-14
Abstract: The invention provides a light generating device (1000) configured to generate device light (1001), wherein the light generating device (1000) comprises (i) a first light source (110) configured to generate blue first light source light (111), wherein the first light source (110) is a first laser light source (10), (ii) a first luminescent material (210) configured to convert part of the blue first light source light (111) into first luminescent material light (211) having an emission band having wavelengths in one or more of the green and yellow, (iii) an optical filter (410) configured to optically filter the first luminescent material light (211) into optically filtered first luminescent material light (213), whereby the optically filtered first luminescent material light (213) is red-shifted relative to the first luminescent material light (211), and (iv) a second light source (120) configured to generate red second light source light (121), wherein the second light source (120) comprises a second laser light source (20); wherein in one or more operational modes of the light generating device (1000) the light generating device (1000) is configured to generate white device light (1001) comprising the first light source light (111), the optically filtered first luminescent material light (213), and the second light source light (121).
Patent EP-4021522-A1 (EP)
Title: Barrière anti-adhérence électrofilée
Inventor: HARRIS JEREMY J
IPC: A61L31/14
Filed: 2020-08-28
Abstract: Selon l'invention, un article comprend un mat fibreux de résine de poly(glycérol sébacate) (PGS) et une résine d'un polymère formant un hydrogel, de type alcool polyvinylique (PVOH). Des procédés de fabrication de tels articles comprennent l'électrofilage d'une combinaison de résine PGS et de résine PVOH pour former des nanofibres et le dépôt des nanofibres sur une surface pour former le mat fibreux. Le mat est approprié pour une variété d'utilisations médicales, notamment en tant que barrière qui peut être déployée dans des interventions chirurgicales.
Patent EP-3941389-A1 (EP)
Inventor: JOHNSON GARRETT
IPC: A61F2/00
Filed: 2020-03-16
Abstract: Improved prosthetic valves, their methods of manufacture, and systems and devices for manufacturing the valves are described. The prosthetic valves can be configured for transcatheter implantation. The prosthetic valves can have artificial leaflets. The prosthetic valves can be manufactured in numerous ways, such as by polymeric dipping processes and/or electrospinning. Sponge-like polymers for valves and other medical devices are also disclosed.
Patent EP-3941169-A1 (EP)
Title: Photosensor
Inventor: TAKAHASHI SHUNYA
IPC: H05K7/00
Filed: 2020-03-10
Abstract: Provided is a photosensor in which a cable can be easily mounted on a circuit board. A photosensor 1 is provided with: a housing 2; a cable 5; a first circuit board 3; and a second circuit board 4. A through-hole 24 is formed in the housing 2. The cable 5 is inserted into the through-hole 24. The first circuit board 3 and the second circuit board 4 are accommodated in the housing 2. The first circuit board 3 is provided with a first connector 34. The second circuit board 4 has a first portion 41 and a second portion 42. The cable 5 is soldered to the first portion 41. The second portion 42 is provided with a second connector 44. The second connector 44 is inserted into the first connector 34. The second circuit board 4 connects the cable 5 and the first circuit board 3.
Patent EP-4027938-A1 (EP)
Inventor: ERCOLANI CARLO
IPC: A61C15/00
Filed: 2020-08-27
Abstract: A veterinary medical device (1) to remove deposits of substances colonizable by pathogens; the device (1) having a support (10) that is elongated according to a given direction (D) and has an end section (11) longitudinally delimited by a rounded end (12) and by a bottom portion (14); the end section (11) comprising two faces (110) (112) opposite to one another which develop between the end (12) and the bottom portion (14); a first face (110) of the two opposing faces (110)(112) having a wedge-shaped cuspate lug (1100) and a second face (112) of the two opposing faces (110)(112) having a pair of projections (1120)(1120') arranged and shaped symmetrically.
Patent EP-3950138-A1 (EP)
Inventor: SENDA GO
IPC: B01L3/14
Filed: 2020-03-18
Abstract: The occurrence of liquid leaking from a specimen container is inhibited. The specimen container 100 includes a container main body 20 including an opening 21 and a cap 10 arranged to close the opening 21 of the container main body 20 and including a slit 111 formed to allow an aspiration tube 30 to pass therethrough. The cap 10 includes a slit-formed portion 11 in which the slit 111 is formed and an elastic portion 12 provided to surround the slit-formed portion 11 and that is elastically deformed to movably support the slit-formed portion 11.
Patent EP-3933027-A1 (EP)
Inventor: GAO YIBO
IPC: C12M1/00
Filed: 2020-03-26
Abstract: The present invention provides a self-driven microfluidic chip and a use method thereof. The self-driven microfluidic chip of the present invention comprises a base and a cover, and a sample inlet, a sample outlet, a plurality of reaction chambers and one or a plurality of primary channels are formed between the base and the cover; the sample inlet and the sample outlet can be communicated with the outside, the primary channels are communicated with the sample inlet and the sample outlet, and a liquid inlet channel and a liquid outlet channel are arranged between each reaction chamber and one primary channel; the internal surfaces of the primary channels, the reaction chambers, the liquid inlet channels and the liquid outlet channels, which are located on the base and/or the cover, are hydrophilic surfaces, the cross sectional area of each liquid inlet channel is less than that of each liquid outlet channel, and in the liquid flow direction in the primary channels, each liquid inlet channel is located in front of each liquid outlet channel; and after the solution of the sample to be tested enters the reaction chambers, the primary channels can be filled with an oil phase reagent to close the liquid inlet channels and the liquid outlet channels. The self-driven microfluidic chip of the present invention realizes the self-driven flow sampling of the solution of the sample to be tested without external drive equipment.
Patent EP-4062433-A1 (EP)
Title: Elektromagnetische betätigungseinrichtung
Inventor: SCHUDT KLAUS
IPC: H01F7/16
Filed: 2020-09-21
Abstract: Eine Elektromagnetische Betätigungseinrichtung (10) umfasst eine sich entlang einer Axialrichtung (46) erstreckende Polhülse (34) und einen radial innerhalb der Polhülse (34) angeordneten Anker (32), wobei die Polhülse (34) ein erstes axiales Ende (48) und ein zweites axiales Ende (50) aufweist, und wobei der Anker (32) innerhalb der Polhülse (34) geführt ist. Es wird vorgeschlagen, dass die Polhülse (34) in einem zwischen den axialen Enden (48, 50) liegenden Bereich (56) Ausnehmungen (62) aufweist, deren Kontur sich entlang der Axialrichtung (46) jeweils verändert.
Patent EP-4031810-A1 (EP)
Inventor: VANDAMME FRANÇOIS
IPC: F22B37/26
Filed: 2020-09-07
Abstract: Die Erfindung betrifft einen Dampferzeugerflüssigkeitsabscheider (10) für einen vertikal mit Dampf durchströmten Dampferzeuger (60), wobei eine Anzahl von Drallblechen (26) um eine Achse in einem Rohrstück angeordnet ist. Jedes Drallblech (26) ist mit dem Rohrstück verbunden, wobei die Drallbleche (26) so geformt sind, dass ein Dampfstrom durch das Rohrstück zusätzlich zu seiner Längsbewegung durch das Rohrstück in eine Rotationsbewegung versetzt ist. Zudem weist das Rohrstück mehrere Rohrteilstücke (30) auf. Eine Achse weist außerdem mehrere Achsteilstücke (28) auf und jedes Drallblech (26) ist mit einem Rohrteilstück (30) und mit einem Achsteilstück (28) zu einem Flüssigkeitsabscheiderteilstück (12, 14, 16, 18) verbunden. Schließlich sind die Achsteilstücke (28) mit einen Achsteilstückhalter (20) formschlüssig lösbar verbunden und die Achsteilstücke (28) sind durch das formschlüssige Verbinden an ihrer konstruktiv vorgesehenen Position gehalten. Zudem betrifft die Erfindung ein Verfahren zur Herstellung des Dampferzeugerflüssigkeitsabscheiders.
Patent EP-3930518-A1 (EP)
Inventor: ILLIDGE BENJAMIN
IPC: A24F40/485
Filed: 2020-09-21
Abstract: A smoking substitute apparatus is disclosed, having: an air inlet; an outlet; and a flow passage formed between the air inlet and the outlet. A vaporisation chamber is in communication with the flow passage, the vaporisation chamber having an aerosol generator configured to generate an aerosol from an aerosol precursor by heating. The aerosol generator comprises a vaporiser element loaded with aerosol precursor, the vaporiser element being heatable by a heater and presenting a vaporiser element surface to air in the vaporisation chamber. A vaporiser element region is defined as a volume extending outwardly from the vaporiser element surface to a distance of 1 mm from the vaporiser element surface. The air inlet, flow passage, outlet and the vaporisation chamber are configured so that, when the air flow rate inhaled by the user through the apparatus is 1.3 L min-1, the maximum magnitude of velocity of air in the vaporiser element region is in the range 0-2.0 ms-1.
Patent EP-4037657-A1 (EP)
Title: A punica granatum extract and its cosmetic uses
Inventor: PANNAKAL STEVE
IPC: A61K8/9789
Filed: 2020-09-30
Abstract: The present invention concerns an extract of  Punica granatum  comprising : i. at least 10% by weight of the total weight of the dry extract, of punicalagins; and ii. at least 10% by weight of the total weight of the dry extract, of ellagic acid; and wherein the weight ratio [ellagic acid/punicalagins] is ranging from 0.5 to 2. The present invention also relates to a method of preparation of the said extract. Another object of the present invention is a preparation comprising the said extract and at least one water-miscible organic solvent preferably chosen from lower alcohols containing from 2 to 8 carbon atoms and in particular from 2 to 6 atoms. The present invention also concerns a composition comprising the said extract or preparation; a process for the cosmetic treatment of keratin materials, comprising a step of applying the said composition and cosmetic uses of the said extract.
Patent EP-4045591-A1 (EP)
Inventor: RUTHARD CHRISTIAN
IPC: C08L25/12
Filed: 2020-10-13
Abstract: L'invention concerne une composition de moulage (P) comprenant : (A) de 81,7 à 99,4 % en poids d'au moins une composition de polymère thermoplastique (A) ; (B) au moins une composition de photostabilisant à base d'amine encombrée (B) comprenant : (B-1) de 0,1 à 0,9 % en poids d'un mélange de photostabilisant à base d'amine encombrée ayant une structure de monopipéridine, (B-2) de 0 à 0,4 % en poids d'au moins un photostabilisant à base amine encombrée ayant une structure de dipipéridine avec au moins un groupe alkyle à chacune des positions 2 et 6 de la structure de dipipéridine et (B-3) de 0,5 à 2 % en poids d'au moins un photostabilisant à base d'amine encombrée ayant une structure polymère comprenant des groupes pipéridine (C) de 0 à 10 % en poids d'un ou de plusieurs colorants, teintures et/ou pigments (C) ; et (D) de 0 à 5 % en poids, sur la base du poids total de la composition de moulage (P), d'un ou de plusieurs additifs supplémentaires (D) ; la somme des constituants (A) à (D) atteignant 100 % en poids de la composition de moulage (P).
Patent EP-4040999-A1 (EP)
Title: Matériau aérosolisable
Inventor: DAVIS MICHAEL FOSTER
IPC: A61K31/352
Filed: 2020-10-08
Abstract: L'invention concerne un matériau aérosolisable comprenant du (+)-cannabidiol et au moins un constituant porteur.
Patent EP-3962560-A1 (EP)
Inventor: HOLLEY LIAM
IPC: A61M16/00
Filed: 2020-05-01
Abstract: A processor associated with a respiratory therapy device (7040) applies acoustic techniques such as for airpath component identification. The device may include a pressure generator configured to generate a supply of pressurized air from an outlet along an air circuit to a patient interface. The device may include a sensor configured to generate a sound signal representing a sound in the air circuit. The device may include a dampening structure configured to reduce reflection of sound from the flow generator along the air circuit. The processor, such as of a controller, may be configured to process the sound signal so as to identify the patient interface and / or the air circuit. The processing may detect and combine acoustic signatures, such as by alignment and averaging, and/or may flatten a spectrum of the sound signal.
Patent EP-4014475-A1 (EP)
Title: End-to-end camera architecture for display module
Inventor: CHOI SANGMOO
IPC: H04M1/02
Filed: 2020-10-06
Abstract: A display module is described that has two or more front-facing camera modules at opposing edges of a computing device. Using images acquired by both camera modules, when a user is looking directly at the display, it is possible to generate an image of the user as though he/she was looking directly toward the lens of a camera module.
Patent EP-4052497-A1 (EP)
Inventor: MATE SUJEET SHYAMSUNDAR
IPC: H04S7/00
Filed: 2020-10-29
Abstract: There is provided an apparatus comprising means for receiving spatial audio capture requirement(s) of one or more user devices; determining position and/or orientation information of the one or more user devices; generating one or more privacy masks at least partly based on the spatial audio capture requirement(s) and position and/or orientation information of the one or more user devices; and transmitting the generated privacy masks to the one or more user devices.
Patent EP-4066144-A1 (EP)
Title: Optimisation de géométrie de corps mis en forme et outils de fabrication
Inventor: KAUFMAN RECHULSKI MARCELO DANIEL
IPC: G06F111/06
Filed: 2020-11-26
Abstract: L'invention concerne un procédé informatisé (124) destiné à concevoir au moins un outil de mise en forme (126), un procédé informatisé (138) destiné à concevoir un processus de fabrication destiné à fabriquer au moins un corps mis en forme (112), un système de conception (170) d'outils de mise en forme destiné à concevoir au moins un corps mis en forme (112) et un système de conception de fabrication destiné à concevoir un processus de fabrication destiné à fabriquer au moins un corps mis en forme (112). Le procédé informatisé (124) destiné à concevoir au moins un corps mis en forme (112) consiste : i) à récupérer, au moyen d'au moins une interface (172), au moins un ensemble de critères cibles de mise en forme pour l'outil de mise en forme (126) ; ii) à définir, au moyen d'au moins une unité de définition de géométrie (174), au moins une géométrie de départ pour l'outil de mise en forme (126) ; iii) à générer, au moyen d'au moins une unité de génération de paramètres de mise en forme (176), un ensemble de paramètres de mise en forme comprenant au moins un paramètre de géométrie de forme de la géométrie de départ ; iv) à simuler, au moyen d'au moins une unité de simulation (178), un processus de mise en forme utilisant l'outil de mise en forme (126) en faisant varier les valeurs de l'ensemble de paramètres de mise en forme et en comparant des propriétés de mise en forme simulées pour ces valeurs à l'ensemble de critères cibles de mise en forme, générant ainsi au moins une géométrie de mise en forme ayant un ensemble de paramètres de mise en forme adapté pour lequel les critères cibles de mise en forme sont satisfaits au moins dans une tolérance préétablie ; et v) à déterminer, au moins d'au moins une unité de définition de géométrie d'outil de mise en forme (180), au moins une géométrie de l'outil ou des outils de mise en forme (126) à partir de l'ensemble de paramètres de mise en forme adapté.
Patent EP-3976064-A1 (EP)
Title: Methods and apparatuses for patient-derived micro-organospheres
Inventor: SHEN XILING
IPC: G01N33/48
Filed: 2020-04-01
Abstract: Micro-Organosphers, including Patient-Derived Micro-Organospheres (PMOSs), apparatuses and methods of making them, and apparatuses and methods of using them. Also described herein are methods and systems for screening a patient using these Patient-Derived Micro-Organospheres, including personalized therapies.
Patent EP-3979056-A1 (EP)
Title: Icon moving method and terminal device
Inventor: WU LINGMIN
IPC: G06F3/0481
Filed: 2020-04-22
Abstract: The present disclosure provides an icon moving method and a terminal device. The method includes: (101), receiving a first input performed by a user for a first application icon in a first home screen interface; (102), displaying an indication identifier and a thumbnail of a second home screen interface in response to the first input, where an indication end of the indication identifier points to a first position in the thumbnail of the second home screen interface; (103), receiving a second input performed by the user; and (104), controlling, in response to the second input, the first application icon to move to a second position, corresponding to the first position, in the second home screen interface.
Patent EP-3955104-A1 (EP)
Inventor: XIONG LIUDONG
IPC: G06F3/14
Filed: 2020-05-26
Abstract: This application discloses a screen projection method, including: First, an electronic device displays M application interfaces on a display of the electronic device, where M is an integer greater than 1. Then, the electronic device receives a first selection operation, and determines N application interfaces based on the first selection operation, where the first selection operation is performed on the electronic device to determine the N application interfaces from the M application interfaces, and N is a positive integer less than or equal to M. Then, the electronic device sends first data to an external display device in response to the first selection operation, where the first data is used by the external display device to display the N application interfaces. In this way, when split-screen displaying a plurality of application interfaces, the electronic device can select one or more of the plurality of application interfaces and project the one or more application interfaces onto a large-screen display, to ensure that an application interface involving user privacy is projected only after a user agrees and confirms. This protects user privacy.
Patent EP-4054539-A1 (EP)
Inventor: SALEEM-UDDIN MOIN AHSON
IPC: A61K31/663
Filed: 2020-11-05
Abstract: A compound for use in the treatment of nephrotic syndrome in a subject in need thereof, wherein the compound is an inhibitor of binding between a target protein and keratin 8.
Patent EP-4070522-A1 (EP)
Inventor: GEERINCK XAVIER
IPC: H04N21/462
Filed: 2020-11-10
Abstract: A stream tool is disclosed that allows a user to seamlessly connect with the different data streams, regardless of the streams' transmission platforms or communication protocols, in order to visually see a representation of the type of data that the data streams are transmitting. A user may specify a particular data stream and provide corresponding connection details. A collection of abstracted software functions enable interaction with the different stream platforms and protocols. Using these abstracted functions, a stream-processing service accesses a requested data stream and samples its data events for either sample timeframe or up to a threshold number of data events. The sampled data events are parsed and visually presented to the user in an easy-to-understand format. The user may then inspect the data stream's data for use in developing robust applications that may integrate and use such data.
Patent EP-4051112-A1 (EP)
Inventor: HONARBAKHSH SHOHREH
IPC: A61B5/367
Filed: 2020-10-29
Abstract: A computer implemented method and system are described that identify one or more regions of the heart responsible for supporting or initiating abnormal heart rhythms. Electrogram data is used that has been recorded from a plurality of electrodes on multipolar cardiac catheters obtained from a corresponding series of sensing locations on the heart over a recording time period. The method includes the steps of: identifying, from the electrograms, regions within a chamber of the heart which have electrical activation sequences which characterize them as potential drivers of abnormal heart rhythms, for each sensing location at or substantially about said region, determining from predominant activations, an earliest activating electrode site; for each determined earliest activating electrode site: calculating a value for each of a plurality of modifiers associated with the electrode site, the modifiers being determined from the electrogram data for the site, tissue characteristics of the site or anatomical characteristics of the site; determining a ranking factor calculated from the plurality of modifiers; ranking the each of said earliest activating electrode sites in dependence on its ranking factor; and, outputting data identifying said regions, the data varying prominence of each of the determined earliest activating electrode sites in dependence on said ranking.
Patent EP-4058453-A1 (EP)
Inventor: PARSONS ANDREW T
IPC: C07F5/05
Filed: 2020-11-13
Abstract: La présente invention concerne un procédé amélioré, efficace et évolutif pour préparer des composés intermédiaires, tels que 2,2', 2"-(1,3,5,2,4,6-trioxatriborinane)-2,4,6-triyle)tris(3-fluorophénol), utile pour la synthèse de composés, tels que le composé 9, pour le traitement de cancers mutés de KRAS G12C.
Patent EP-4077726-A1 (EP)
Title: Kits and flow cells
Inventor: GEORGE WAYNE N
IPC: C12Q1/6869
Filed: 2020-11-25
Abstract: An example of a kit includes a flow cell and a cleavage mix. An example flow cell includes a substrate; a catalytic polymeric hydrogel on the substrate, the catalytic polymeric hydrogel including a deblocking catalyst; and an amplification primer attached to the catalytic polymeric hydrogel. The deblocking catalyst accelerates cleavage of a blocking group of a 3' OH blocked nucleotide introduced to the flow cell and incorporated into a template strand attached to the amplification primer. An example of the cleavage mix includes a component to initiate cleavage of the blocking group.
Patent EP-4058492-A1 (EP)
Inventor: BRANDT DAMIEN
IPC: C08G8/10
Filed: 2020-11-30
Abstract: L'invention a trait à un procédé de préparation d'une résine phénolique de type résol comprenant les étapes suivantes : a) une étape de condensation du phénol et du formaldéhyde, en milieu basique, le formaldéhyde étant en excès molaire par rapport au phénol, à une température de condensation d'au moins 50°C jusqu'à ce que le taux de conversion du phénol soit de 50 à 80%, moyennant quoi il résulte une résine phénolique de type résol comprenant du formaldéhyde libre; b) une étape de mesure de la teneur en formaldéhyde libre de la résine phénolique obtenue en a); c) une étape de diminution de la teneur en formaldéhyde libre de la résine phénolique obtenue en a) par mise en contact de celle-ci avec un composé aminophénolique en quantité excédentaire par rapport au formaldéhyde libre et à une température inférieure à la température de condensation de l'étape a).
Patent EP-4069841-A1 (EP)
Title: Targeted transfer rnas for treatment of diseases
Inventor: HUSS DAVID
IPC: A61K31/7088
Filed: 2020-12-01
Abstract: Provided are engineered tRNA molecules and vectors encoding engineered suppressor tRNA molecules that recognize and readthrough of disease-causing premature stop codons. Pharmaceutical formulations of the engineered tRNA or vectors encoding the engineered tRNA are provided for use in treating diseases associated with truncation of a protein caused by premature stop codons present in the nucleic acid sequence encoding the protein.